TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.

The current price of 600211 is 46.28 CNY — it has increased by 0.33% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stocks are traded under the ticker 600211.

600211 stock is 1.85% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. there?

Yes, you can track TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financials in yearly and quarterly reports right on TradingView.

600211 stock has risen by 5.18% compared to the previous week, the month change is a 0.43% rise, over the last year TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. has showed a 25.75% decrease.

600211 net income for the last quarter is ‪−54.43 M‬ CNY, while the quarter before that showed ‪259.44 M‬ CNY of net income which accounts for −120.98% change. Track more TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financial stats to get the full picture.

TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. dividend yield was 3.97% in 2023, and payout ratio reached 60.03%. The year before the numbers were 2.08% and 50.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 600211 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stock right from TradingView charts — choose your broker and connect to your account.

600211 reached its all-time high on Aug 4, 2020 with the price of 182.07 CNY, and its all-time low was 1.98 CNY and was reached on Jul 20, 2005.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 601.00 employees. See our rating of the largest employees — is TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. stock shows the neutral signal. See more of TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. EBITDA is ‪909.94 M‬ CNY, and current EBITDA margin is 35.56%. See more stats in TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financial statements.